Axsome Therapeutics, Inc.
DE ˙ DB ˙ US05464T1043
199,30 € ↑9,50 (5,01%)
2026-06-04
DEL PRIS
SecurityDE:19X / Axsome Therapeutics, Inc.
InstitutionNorges Bank
Latest Disclosed Ownership495,456 shares
Latest Disclosed Value $ 90,490,084
Norges Bank ownership in 19X / Axsome Therapeutics, Inc.

On February 10, 2026 - Norges Bank filed a 13F-HR form disclosing ownership of 495,456 shares of Axsome Therapeutics, Inc. (DE:19X) valued at $64,161,552 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 13, 2025 disclosing 0 shares of Axsome Therapeutics, Inc.. The current value of the position is $98,744,381 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-02-10 2025-12-31 13F AXSOME THERAPEUTICS COM 05464T104 495,456 495,456 90,490 0.0097
2025-11-13 2025-09-30 13F AXSOME THERAPEUTICS COM 05464T104 0 -468,329 -100.00 0 -100.00
2025-08-13 2025-06-30 13F AXSOME THERAPEUTICS COM 05464T104 468,329 30,832 7.05 48,889 -4.19 0.0061
2026-05-11 2025-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 437,497 34,471 8.55 51,025 49.63 0.0072
2025-02-12 2024-12-31 13F AXSOME THERAPEUTICS COM 05464T104 403,026 11,710 2.99 34,100 -3.03 0.0045
2025-11-12 2024-09-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 391,316 -12,901 -3.19 35,168 8.08 0.0049
2024-08-14 2024-06-30 13F AXSOME THERAPEUTICS COM 05464T104 404,217 18,666 4.84 32,539 5.76 0.0049
2025-05-14 2024-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 385,551 190,428 97.59 30,767 98.12 0.0049
2024-02-09 2023-12-31 13F AXSOME THERAPEUTICS COM 05464T104 195,123 -15,099 -7.18 15,530 5.70 0.0027
2024-11-13 2023-09-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 210,222 0 0.00 14,692 -2.74 0.0030
2024-08-14 2023-06-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 210,222 0 0.00 15,107 16.50 0.0030
2024-05-15 2023-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 210,222 -46,175 -18.01 12,966 -34.43 0.0028
2023-02-14 2022-12-31 13F AXSOME THERAPEUTICS COM 05464T104 256,397 0 0.00 19,776 72.86 0.0048
2023-11-13 2022-09-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 256,397 23,351 10.02 11,440 28.18 0.0030
2023-08-14 2022-06-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 233,046 55,766 31.46 8,926 21.64 0.0023
2023-05-12 2022-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 177,280 -15,049 -7.82 7,338 0.98 0.0016
2022-03-09 2021-12-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 192,329 0 0.00 7,266 14.62 0.0015
2022-11-14 2021-09-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 192,329 130,106 209.10 6,339 51.00 0.0014
2022-08-15 2021-06-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 62,223 -145,699 -70.07 4,198 -64.34 0.0009
2022-05-09 2021-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 207,922 -66,987 -24.37 11,773 -47.43 0.0027
2021-03-02 2020-12-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 274,909 -8,946 -3.15 22,397 10.74 0.0052
2021-11-12 2020-09-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 283,855 -122,343 -30.12 20,225 -39.49 0.0054
2021-08-13 2020-06-30 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 406,198 97,806 31.71 33,422 84.21 0.0096
2021-05-07 2020-03-31 13F/A-1 AXSOME THERAPEUTICS COM 05464T104 308,392 308,392 18,143 0.0065
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.